Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Bethesda North Marriott Hotel and Conference Center

Apr 24, 2017 1:00 PM - Apr 26, 2017 4:30 PM

5701 Marinelli Road, , North Bethesda, MD 20852 , USA

DIA/FDA Statistics Forum

The DIA/FDA Statistics Forum fosters open discussion of timely topics of mutual theoretical and practical interest to biostatisticians and clinical trialists.

Session 3: Alternative Data Sources: Analytical Challenges and Opportunities for Statisticians to Take the Lead

Session Chair(s)

Pandurang M Kulkarni, PhD

Pandurang M Kulkarni, PhD

Chief Analytics Officer-R&D / Vice President of Statistics, Data & Analytics

Eli Lilly and Company, United States

Based on published research, 90 percent of data in the world has been created in just the last two years. This growth is expected to continue at a rate of 40 percent each year. Health care data is a major contributor to this growth, accelerating at a phenomenal rate of 48 percent every year. New technologies also accelerate this speed, such as electronic patient reported outcomes (ePROs), wearable devices, social media, and more. Key challenges are two fold: one is collecting, integrating, and making the data available quickly to be able to draw insights from the data. The other is how to address the variability, and how to make sense of mass data being generated by doctors, researchers, patients, and hospitals, so we can improve patients’ care. These challenges provide opportunities for improvements of current data storage/transfer infrastructure, analyzing methods, and a way to communicate the timely results. In this session, our distinguished speakers will provide their visionary insights and their recent works around these areas.

Learning Objective :

At the conclusion of this session, participants should be able to:

  • Understand data, technology, and analytics methods to address your health care questions with data from alternative sources

Speaker(s)

Laura Lee  Johnson, PhD

Session Co-Chair

Laura Lee Johnson, PhD

FDA, United States

Director, Division of Biometrics III, Office of Biostatistics, OTS, CDER

Jesse  Bridgewater

Predicting Health Metrics with Connected Glucose Monitoring

Jesse Bridgewater

Livongo, United States

Vice President, Data Science

Marie  Schiller

From Logbooks to Closed Loop Systems – How Data is Changing Diabetes Care

Marie Schiller

Lilly and Company, United States

Vice President, Drug Delivery/Device R&D Innovation

David M. Petullo, MSc

David M. Petullo, MSc

FDA, United States

Mathematical Statistician, OB, OTS, CDER

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.